<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Determining the percentage of peripheral blood (PB) and bone marrow (BM) blasts is important for diagnosing and classifying <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Although most patients with <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> have a higher percentage of BM blasts than PB blasts, the relative proportion is reversed in some patients </plain></SENT>
<SENT sid="2" pm="."><plain>We explored the clinical relevance of this phenomenon in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (n = 446), <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> (n = 1314), and <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL) (n = 385) </plain></SENT>
<SENT sid="3" pm="."><plain>Among patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> or ALL, but not <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, having a higher blast percentage in PB than in BM was associated with significantly shorter survival </plain></SENT>
<SENT sid="4" pm="."><plain>In multivariate analyses, these associations were independent of other relevant predictors, including cytogenetic status </plain></SENT>
<SENT sid="5" pm="."><plain>Our findings suggest that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and ALL patients who have a higher percentage of PB blasts than BM blasts have more <z:e sem="disease" ids="C0001807" disease_type="Mental or Behavioral Dysfunction" abbrv="">aggressive disease</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>These data also suggest that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> classification schemes should take into account the percentage of blasts in PB differently from the percentage of blasts in BM </plain></SENT>
</text></document>